Breast Cancer Research

official impact factor 5.79

Highly Access

HER2 therapy: Molecular mechanisms of trastuzumab resistance

Rita Nahta and Francisco J Esteva

Breast Cancer Research 2006, 8:215 doi:10.1186/bcr1612

Accesses  

  • Last 30 days: 289 accesses
  • Last 365 days: 3250 accesses
  • All time: 17231 accesses

Cited by